Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Methamphetamine treatment: trends and predictors of retention and completion in a large state treatment system (1992-2002).

Brecht ML, Greenwell L, Anglin MD.

J Subst Abuse Treat. 2005 Dec;29(4):295-306.

PMID:
16311182
2.

Profiles associated with treatment retention in Japanese patients with methamphetamine use disorder: preliminary survey.

Kobayashi O, Matsumoto T, Otsuki M, Endo K, Okudaira K, Wada K, Hirayasu Y.

Psychiatry Clin Neurosci. 2008 Oct;62(5):526-32. doi: 10.1111/j.1440-1819.2008.01845.x.

3.

The rise in treatment admissions for methamphetamine use in Los Angeles County from 2001 through 2005.

Crèvecoeur D, Rutkowski B, Rawson RA.

J Psychoactive Drugs. 2007 Nov;Suppl 4:383-92.

PMID:
18284104
4.

Two-year outcomes of treatment for methamphetamine use.

Brecht ML, Greenwell L, von Mayrhauser C, Anglin MD.

J Psychoactive Drugs. 2006 Nov;Suppl 3:415-26.

PMID:
17357533
5.

Mothers in substance abuse treatment: differences in characteristics based on involvement with child welfare services.

Grella CE, Hser YI, Huang YC.

Child Abuse Negl. 2006 Jan;30(1):55-73. Epub 2006 Jan 6.

PMID:
16406024
6.

Self-reported health status among treated methamphetamine users.

Greenwell L, Brecht ML.

Am J Drug Alcohol Abuse. 2003;29(1):75-104.

PMID:
12731682
7.

Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health.

Plüddemann A, Myers BJ, Parry CD.

Drug Alcohol Rev. 2008 Mar;27(2):185-9. doi: 10.1080/09595230701829363.

PMID:
18264880
8.

Older admissions to substance abuse treatment in 2001.

Arndt S, Gunter TD, Acion L.

Am J Geriatr Psychiatry. 2005 May;13(5):385-92.

PMID:
15879587
9.

Coerced treatment for methamphetamine abuse: differential patient characteristics and outcomes.

Brecht ML, Anglin MD, Dylan M.

Am J Drug Alcohol Abuse. 2005;31(2):337-56.

PMID:
15912720
10.

Trends in primary methamphetamine-related admissions to youth residential substance abuse treatment facilities in Canada, 2005-2006 and 2009-2010.

Verdichevski M, Burns R, Cunningham JK, Tavares J, Callaghan RC.

Can J Psychiatry. 2011 Nov;56(11):696-700.

PMID:
22114924
11.

Drug use, HIV-related risk behaviors and dropout status of new admissions and re-admissions to methadone treatment.

Deren S, Goldstein MF, Des Jarlais DC, Richman BL, Kang S, Flom PL.

J Subst Abuse Treat. 2001 Mar;20(2):185-9.

PMID:
11306221
12.
13.

Status of methamphetamine users 2-5 years after outpatient treatment.

Rawson RA, Huber A, Brethen P, Obert J, Gulati V, Shoptaw S, Ling W.

J Addict Dis. 2002;21(1):107-19.

PMID:
11831496
14.

Methamphetamine users in northern Thailand: changing demographics and risks for HIV and STD among treatment-seeking substance abusers.

Beyrer C, Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, Kawichai S, Tovanabutra S, Rungruengthanakit K, Sawanpanyalert P, Sripaipan T, Celentano DD.

Int J STD AIDS. 2004 Oct;15(10):697-704.

PMID:
15479508
15.

Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.

Cunningham JK, Liu LM.

Soc Sci Med. 2008 Apr;66(7):1463-73. doi: 10.1016/j.socscimed.2007.12.006. Epub 2008 Jan 28.

PMID:
18222587
16.
17.

Criminal justice itreatment admissions for methamphetamine use in California: a focus on Proposition 36.

Anglin MD, Urada D, Brecht ML, Hawken A, Rawson R, Longshore D.

J Psychoactive Drugs. 2007 Nov;Suppl 4:367-81.

PMID:
18284103
18.

Client retention in residential drug treatment for Latinos.

Amodeo M, Chassler D, Oettinger C, Labiosa W, Lundgren LM.

Eval Program Plann. 2008 Feb;31(1):102-12. doi: 10.1016/j.evalprogplan.2007.05.008. Epub 2007 Jul 4.

PMID:
18222144
19.

Methamphetamine use behaviors and gender differences.

Brecht ML, O'Brien A, von Mayrhauser C, Anglin MD.

Addict Behav. 2004 Jan;29(1):89-106.

PMID:
14667423
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk